A1 adenosine receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07022710

ABSTRACT:
Disclosed are novel methods of antagonizing the A1adenosine receptor in a mammal, comprising administering to a mammal in need thereof a therapeutically effective dose of a compound of the formula:wherein R1is optionally substituted C1-14alkyl; Y is C1-14alkylene; and Z is phenyl that is optionally substituted with halo, hydroxy, amino, cyano, or optionally substituted C1-4alkyl or a pharmaceutically acceptable salt, ester, or prodrug thereof. The A1adenosine receptors are antagonized in order to treat a disease state is chosen from renal failure, renal dysfunction, nephritis, hypertension, edema, Alzheimers disease, stress, depression, cardiac arrhythmia, restoration of cardiac function, congestive heart failure, diabetes, asthma, respiratory disorders, ischemia-induced injury of the brain, heart and kidney, and diarrhea.

REFERENCES:
patent: 6770651 (2004-08-01), Palle et al.
patent: 2003/0050272 (2003-03-01), Palle et al.
patent: 2004/0209899 (2004-10-01), Palle et al.
patent: WO 00/73307 (2000-12-01), None
patent: WO 01/16134 (2001-03-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

A1 adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A1 adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A1 adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3566324

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.